North America
The country saw sweeping IP reform in 2020, but IMPI still needs to implement regulations governing the changes
US biosimilar cases will likely settle and patent thickets could be a bugbear for companies, say three in-house counsel and three private practice lawyers
The Patent Trial and Appeal Board found that claims in a Novartis patent were obvious over the prior art
New expungement proceedings for trademarks have been good tools in litigation, but lawyers must put in the work, say counsel at six US firms
Sponsored
Sponsored
-
Sponsored by OlivaresJorge Juárez of Olivares explains the requirements for applicants aiming to protect industrial designs in designating Mexico and highlights the importance of compliance with the unity of design requirement -
Sponsored by Shiga International Patent OfficeMasato Iida of Shiga International Patent Office calls for greater clarity in the Japanese patent linkage system in comparing it with US and Chinese practice
-
Sponsored by Purplevine IPJoin Ude Lu, the chief IP counsel (US) of Purplevine IP, Helen Zhang, the litigation manager of Purplevine IP in Beijing, and Penny Sun, the brand protection manager of ABRO Industry, as they discuss evidence collection for patent enforcement in China and the US virtually with Managing IP on November 9 at 10am (US ET) / 3pm (UK) / 11pm (China)
North American Jurisdictions